Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$100.0K
20.43K shares
What this filing means
SWARTZ ROBIN plans to sell 20.43K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $100.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2025ACC: 0001959173-25-001193
Officer· Chief Operating Officer
Since Feb 2022
20.43K
Shares to sell
$100.0K
Approx. market value
3.89K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/14/2025
3.89KTotal acquired3.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Restricted Stock Vesting Compensation | 3.89K | — |
| Total | 3.89K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
6.95K
Market value
$30.9K
2/11/2025
—Completed
Units to sell
3.09K
Market value
$15.7K
1/14/2025
—Completed
Units to sell
6.50K
Market value
$36.7K
12/23/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.89K
Market value
$16.6K
2/20/2025
Total
Units
20.43K
Value
$100.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2025 | 6.95K | $30.9K | — | Completed |
1/14/2025 | 3.09K | $15.7K | — | Completed |
12/23/2024 | 6.50K | $36.7K | — | Completed |
| Planned — Approximate Date | ||||
2/20/2025 | 3.89K | $16.6K | NASDAQ | Planned |
| Total | 20.43K | $100.0K | ||